Developer of medical devices and provides treatments for peripheral vascular disease. The company develops procedure to percutaneously remove blood clots from dialysis and peripheral grafts as well as native arteries and veins.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 06-Mar-2009 | 000.00 | Completed | Generating Revenue | ||
7. Later Stage VC | 13-Feb-2008 | 0000 | 000.00 | Completed | Generating Revenue | |
6. Later Stage VC (Series A1) | 17-Dec-2007 | 00.00 | 000.00 | 000.00 | Completed | Product Development |
5. Later Stage VC (Series A1) | 19-Oct-2007 | 000.00 | 000.00 | 000.00 | Completed | Product Development |
4. Later Stage VC (Series D) | 09-Jul-2003 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
3. Later Stage VC (Series C) | 15-Nov-2001 | 00.000 | 000.00 | 000.00 | Completed | Startup |
2. Early Stage VC (Series B) | 03-May-2000 | $7.18M | $8.39M | 0000 | Completed | Startup |
1. Early Stage VC (Series A) | 26-May-1999 | $1.22M | $1.22M | 00.000 | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Atherton Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
De Novo Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Frantz Medical Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Kaiser Permanente Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Saratoga Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |